Log in

NASDAQ:TRNSTranscat Stock Price, Forecast & News

$24.37
-0.24 (-0.98 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.81
Now: $24.37
$24.98
50-Day Range
$23.05
MA: $25.28
$28.12
52-Week Range
$16.50
Now: $24.37
$34.18
Volume8,291 shs
Average Volume27,008 shs
Market Capitalization$180.07 million
P/E Ratio22.56
Dividend YieldN/A
Beta0.68
Transcat, Inc. provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.
Read More
Transcat logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.54 out of 5 stars


Industry, Sector and Symbol

Industry Instruments to measure electricity
Sub-IndustryN/A
Current SymbolNASDAQ:TRNS
CUSIPN/A
Phone585-352-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$173.10 million
Cash Flow$1.90 per share
Book Value$9.09 per share

Profitability

Net Income$8.07 million

Miscellaneous

Employees571
Market Cap$180.07 million
Next Earnings Date7/28/2020 (Estimated)
OptionableNot Optionable

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

Transcat (NASDAQ:TRNS) Frequently Asked Questions

How has Transcat's stock been impacted by COVID-19 (Coronavirus)?

Transcat's stock was trading at $27.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TRNS stock has decreased by 12.4% and is now trading at $24.37. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Transcat?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Transcat.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Transcat.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) announced its quarterly earnings data on Tuesday, May, 19th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.28 by $0.05. The scientific and technical instruments company earned $45.76 million during the quarter, compared to analysts' expectations of $45.50 million. Transcat had a return on equity of 12.64% and a net margin of 4.66%. View Transcat's earnings history.

What price target have analysts set for TRNS?

4 brokerages have issued 12-month target prices for Transcat's stock. Their forecasts range from $34.50 to $42.00. On average, they expect Transcat's stock price to reach $36.63 in the next year. This suggests a possible upside of 50.3% from the stock's current price. View analysts' price targets for Transcat.

Has Transcat been receiving favorable news coverage?

Media stories about TRNS stock have been trending negative this week, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Transcat earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Transcat.

Are investors shorting Transcat?

Transcat saw a decrease in short interest in June. As of June 30th, there was short interest totaling 50,200 shares, a decrease of 11.3% from the June 15th total of 56,600 shares. Based on an average daily volume of 28,900 shares, the short-interest ratio is currently 1.7 days. Approximately 0.7% of the shares of the company are short sold. View Transcat's Current Options Chain.

Who are some of Transcat's key competitors?

What other stocks do shareholders of Transcat own?

Who are Transcat's key executives?

Transcat's management team includes the following people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 55)
  • Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 59)
  • Mr. Robert A. Flack, VP of Service Sales & Operations (Age 49)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 53)
  • Mr. Michael W. West, VP of Inside Sales & Marketing (Age 48)

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (2.17%). Company insiders that own Transcat stock include Carl E Sassano, Charles P Hadeed, Gary J Haseley, John T Smith, Michael Tschiderer, Richard J Harrison, Robert A Flack and Scott Deverell. View institutional ownership trends for Transcat.

Which major investors are buying Transcat stock?

TRNS stock was acquired by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. Company insiders that have bought Transcat stock in the last two years include Gary J Haseley, and Michael Tschiderer. View insider buying and selling activity for Transcat.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $24.37.

How big of a company is Transcat?

Transcat has a market capitalization of $180.07 million and generates $173.10 million in revenue each year. The scientific and technical instruments company earns $8.07 million in net income (profit) each year or $1.08 on an earnings per share basis. Transcat employs 571 workers across the globe.

What is Transcat's official website?

The official website for Transcat is www.transcat.com.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.